pt141 peptide oral PT-141 PT-141 | FancyMeds

A comprehensive review identifies three innovative nanotechnology-driven strategies aimed at targeting and altering white adipose tissues (WATs) and their vasculature to combat obesity

Biographical Sketch of 464

100% bioavailability

Plasma glucose was measured using commercial kits (Asan Pharmaceutical Co.,Hwaseong-si Gyeonggi-do, Korea), the plasma FFA level using a non-esterified fatty acid kit (Wako Pure Chemical Industries), the plasma insulin level was determined with an enzyme-linked immunosorbent assay kit (Morinaga Bioscience Laboratory, Yokohama, Japan), and the plasma glycerol level was determined using the colorimetric assay kit (Cayman CO., Ellsworth RD, USA) according to the instruction of the manufacturer

Source: New York University School of Medicine Filed Under: Drug Discovery